mRNA Hantavirus Shot
The article argues that commercial rationale for a hantavirus shot is difficult to understand because the disease is rare and outbreaks are historically small. The mRNA platform may allow faster shot development, but the article questions…
1 sources - 5 claims
The article argues that commercial rationale for a hantavirus shot is difficult to understand because the disease is rare and outbreaks are historically small. The mRNA platform may allow faster shot development, but the article questions whether emerging viral syndromes will increasingly trigger new mRNA products. Testing efficacy for a hantavirus shot would be difficult because natural exposure is uncommon. Hantavirus being described as a single-stranded RNA virus raises concern that mutation could make durable shot effectiveness difficult. News coverage reported that Moderna was working on an mRNA shot for hantavirus.